RxDoctor Payments Data

Brad Karon, MD

Clinical Pathology/Laboratory Medicine · Rochester, MNNPI 1992782437

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,750 of the $6,455 with a category attached, or 89.1%. Roche Diagnostics Corporation accounts for 75.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $3,234 and has fallen 94.7% since, to $173 in 2023.

$6,455in general payments, 2019–2025

Across 11 payments — averaging $586.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$5K
  • Radiometer America, Inc$1K
  • Werfen USA LLC$130
  • E.r. Squibb & Sons, L.L.C.$61
$2,153in research payments, 2019–2025

Across 2 payments — averaging $1076.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BD$2K

What the payments were for

  • Consulting fees$5,75089%
  • Travel & lodging$1683%
  • Food & beverage$5378%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Roche Diagnostics Corporation7$4,882
Radiometer America, Inc2$1,382
Werfen USA LLC1$130
E.r. Squibb & Sons, L.L.C.1$61

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,455 in reported general payments places this provider in the 80th percentile of 30 clinical pathology/laboratory medicine providers in Minnesota.

See all clinical pathology/laboratory medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$158,518
Medicare patients
7,505
Services billed
21,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →